Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank57
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-102.16M
↓ 16% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-88.38M
Historical baseline
PeriodValueYoY Change
TTM$-102.16M+25.9%
2024$-137.94M-5.2%
2023$-131.11M-7.3%
2022$-122.22M-8.3%
2021$-112.82M-93.8%
2020$-58.22M-110.0%
2019$-27.73M-87.0%
2018$-14.83M-